Top Stories
-
Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.
Topic
-
Columbia scientists have found that breast cancer patients who are HIV-positive are 40% more likely to have triple-negative breast cancer—the most aggressive subtype—than patients without HIV.
Topic
-
Norovirus, the most common stomach bug in the United States, makes the rounds every winter. Our expert GI doctor gives tips on how to avoid this highly contagious illness and what to do if you get it.
Topic
-
Researchers have learned how to stimulate the immune system in animal models to produce large quantities of broadly neutralizing antibodies against HIV—a prerequisite for an effective vaccine.
Topic
Latest News
- January 12, 2021
Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Topic
- January 11, 2021
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
Topic
- January 5, 2021
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Topic
- December 31, 2020
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
Topic
- December 23, 2020
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
Topic
- December 21, 2020
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
Topic
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Topic
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Topic
- November 30, 2020
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.
Topic
- November 30, 2020
On World AIDS Day, David Ho, MD, received the National Leadership Recognition Award from the National AIDS Memorial and spoke at a virtual event about the impacts of HIV/AIDS and COVID-19.
Topic
